Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Notes Payables (2022)

CervoMed's Notes Payables history spans 6 years, with the latest figure at $12.4 million for Q4 2022.

  • For Q4 2022, Notes Payables changed N/A year-over-year to $12.4 million; the TTM value through Dec 2022 reached $12.4 million, changed N/A, while the annual FY2022 figure was $12.4 million, N/A changed from the prior year.
  • Notes Payables for Q4 2022 was $12.4 million at CervoMed, up from $200000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $12.4 million in Q4 2022 and bottomed at $12.4 million in Q4 2022.